Quantigen is preparing to move from its current home near Allisonville Road & 116th Street to new quarters in the remodeled Round Room building, north of 116th Street along I-69. The firm, specializing in medical diagnostics and device development through pharmaceutical and biotech industry partnership, will occupy 40,000 square feet in the new location.
The company plans to add 30 new, high-wage jobs in the areas of quality & regulatory compliance and research by the end of 2023 and will invest $2.5 million into new lab and office space. Quantigen will essentially be doubling its work force.
“The Fishers community has been home to Quantigen since our founding, so we are thrilled to have been able to find a facility that can support our expansion and allow us to continue operations in the city where we have been welcomed and supported,” said Quantigen CEO Jami Elliott in a city news release. “Mayor Fadness and his team have been incredibly supportive throughout our relocation search process. We are bullish for Quantigen’s future, as we are for the biotech prospects for our city and the region as a whole”
According to the release, the firm will be increasing activity in three areas:
• Increased demand from pharma and biotech companies to develop new diagnostic tests and platform technologies.
• Support for grant sponsored research through the Bill & Melinda Gates Foundation in the areas of high throughput test development for soil transmitted helminths, COVID-19 and Tuberculosis.
• A recent U.S. Centers for Medicare and Medicaid Services MolDx coverage decision award for a novel genetic test that is used to aid health care providers in medication selection and to improve medication safety.
“Jami and his team at Quantigen are working on next-generation technology for the life science industry right here in Fishers,” said Fishers Mayor Scott Fadness. “Quantigen’s commitment to staying and investing in this community is exciting as we continue to see catalytic growth in this cluster that’s ripe for Fishers.”
The State of Indiana is offering up to $350,000 in conditional tax credits based on the company’s plans to create up to 23 new jobs by the end of 2023. These tax credits are performance-based, meaning the company is eligible to claim incentives once employees are hired at the Fishers location.
The City of Fishers is providing Quantigen with a $50,000 grant toward its buildout and moving expenses. The Redevelopment Commission approved the Economic Development Agreement at the February 2 meeting with the abatement approval being presented to City Council at the July meeting.
This is part of a strategy by the City of Fishers and Mayor Fadness to grow the life science industry here. Italian company Stevanato already announced plans for a new facility near 126th Street and Cumberland Road.